Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Bezisterim by BioVie for Alzheimer's Disease: Likelihood of Approval
Bezisterim is under clinical development by BioVie and currently in Phase III for Alzheimer's Disease. According to GlobalData, Phase III...
Data Insights
Bezisterim by BioVie for Mild Cognitive Impairment: Likelihood of Approval
Bezisterim is under clinical development by BioVie and currently in Phase II for Mild Cognitive Impairment. According to GlobalData, Phase...